Best Glaucoma Specialist in Gurgaon

Dr Shibal Bhartiya‘s Credentials at a Glance:

  • 25+ years of experience in ophthalmology
  • Fellowship-trained glaucoma specialist. 3 years dedicated clinical training in glaucoma and cornea, plus concurrent role as Senior Research Associate, AIIMS, New Delhi
  • Structured fellowship, Senior Clinical Research Fellow, Department of Clinical Neurosciences, University of Geneva. Special focus: 24 hour IOP monitoring, Glaucoma lasers, SLT, MIGS )
  • One of few glaucoma specialists also specifically trained in optic neuropathies
  • Mayo Clinic Research Collaborator (current)
  • Executive Editor, Journal of Current Glaucoma Practice
  • 200+ peer-reviewed publications, 90+ on PubMed
  • 28+ edited ophthalmology textbooks
  • 1,580+ five-star patient reviews on Google, Gurgaon practice

Quick Answer: Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist in Gurgaon with over 25 years of experience in ophthalmology. Her training included three years of dedicated glaucoma and cornea clinical training, alongside a concurrent role as Senior Research Associate, at AIIMS New Delhi. This was followed by a structured fellowship in glaucoma in the Department of Clinical Neurosciences at the University of Geneva, with a focus on MIGS. This combination makes her one of a small number of glaucoma specialists also specifically trained in optic neuropathies. Dr Bhartiya is also uniquely positioned to manage glaucoma-related ocular surface disease and dry eye, given her parallel cornea training.

Dr Shibal Bhartiya is a current Mayo Clinic Research Collaborator. She has published more than 200 peer-reviewed papers, and has edited over 28 ophthalmology textbooks. She serves as Executive Editor of the Journal of Current Glaucoma Practice. Across her Gurgaon practice’s 1,580+ verified five-star reviews, patients consistently describe feeling heard and treated as individuals, not just diagnoses, with tests, treatment plans, and disease explained in plain language.

Best Glaucoma Specialist in Gurgaon: What Sets Fellowship-Trained Glaucoma Care Apart

Searching for “best glaucoma specialist Gurgaon” usually surfaces a mix of general ophthalmologists, multi-specialty hospital listings, and very few fellowship-trained subspecialists. The difference matters more in glaucoma than almost any other eye condition. It is a disease that is silent until vision is already lost. The treatment decisions made early determine how much sight is preserved over a lifetime. Also, glaucoma rarely exists in isolation. Glaucoma patients frequently develop dry eye from long-term drop us. Some may present with overlapping optic nerve conditions that a purely glaucoma-trained eye can miss. This page sets out, plainly, what fellowship-level glaucoma training, cross-disciplinary training, and active research involvement actually mean for a patient sitting in the chair.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care.

Important: Glaucoma has no symptoms until significant, irreversible vision loss has already occurred in most cases. The qualifications and ongoing research engagement of the specialist you choose is important. It directly affects how early disease is caught and how treatment is sequenced.


What Fellowship-Level Glaucoma Training Looks Like

Training ComponentWhat It MeansWhy It Matters for Patients
Glaucoma + cornea clinical training, plus Senior Research Associate, AIIMS New Delhi3 years of concurrent clinical and research immersion across glaucoma and cornea, alongside high volume, complex glaucoma case exposure; ongoing research collaborations with Prof Tanuj Dada, Head of the Glaucoma Unit at AIIMSUniquely positioned to manage glaucoma-related ocular surface disease and dry eye, which most glaucoma-only specialists are not specifically trained to treat
Structured fellowship, Senior Clinical Research Fellow, Dept of Clinical Neurosciences, University of GenevaFellowship under Prof Tarek Shaarawy, a leading international authority on MIGS, within a neurosciences department rather than a standard ophthalmology unitOne of a small number of glaucoma specialists also specifically trained to manage other optic neuropathies, not just glaucoma in isolation
Mayo Clinic Research Collaborator (current)Active, ongoing collaboration with one of the world’s leading glaucoma research groupsTreatment recommendations are informed by current international research, not outdated protocols
Executive Editor, Journal of Current Glaucoma PracticeReviews and shapes published glaucoma research globallyFirst-hand, early access to emerging evidence and treatment shifts
200+ peer-reviewed publications, 28+ edited textbooksSustained contribution to the field’s evidence base, not just clinical practiceIndicates depth of subject mastery beyond routine patient care
1,585+ five-star Google reviews, Gurgaon practiceSustained, high-volume patient satisfaction across years of practice, not a handful of recent reviewsReal-world evidence that credentials translate into consistent, trusted patient experience — patients consistently describe feeling heard, having unhurried conversations, and treatment explained in terms of quality of life, not just disease numbers

When To See a Glaucoma Specialist (Not a General Ophthalmologist)

  • A family history of glaucoma, especially in a parent or sibling
  • High eye pressure found on a routine check, even without symptoms
  • Diabetes, high myopia, or long-term steroid use
  • Already diagnosed with glaucoma and considering a second opinion before surgery
  • Vision loss that your current doctor has not been able to fully explain
  • Persistent dryness, burning, or irritation alongside long-term glaucoma drop use
  • Considering newer surgical options like MIGS before agreeing to traditional surgery
  • Age over 40 with no eye pressure check in the last two years

What 1,580+ Five-Star Reviews Reflect

Patient tip: A high review volume matters less than what reviews consistently describe. Look for patterns, not just star counts. Most patients call her the best eye doctor, or the best glaucoma specialist in Gurgaon! Most also appreciate how friendly she, and how she especially takes care of children. Several patients mention how much her second opinions, as well as teleconsultations, helped them.

Patients consistently talk of her clear, unhurried explanations. They describe two being told clearly what stage their glaucoma is at. They also say that treatment decisions were explained rather than simply prescribed. In a condition where lifelong monitoring and trust matter as much as any single procedure, that consistency across nearly 1,600 reviews is itself a clinical signal.


Book a Consultation

If you’ve been told you have glaucoma, are at risk, or want a second opinion before surgery. Getting a clear, evidence- based, research-informed assessment early protects vision that cannot be regained later. Book an Appointment → contact us | +91 8882638735


Frequently Asked Questions

What makes a glaucoma specialist different from a general eye doctor?

A glaucoma specialist has completed dedicated subspecialty training beyond a general ophthalmology residency. This typically including a fellowship focused entirely on glaucoma diagnosis, surgical management, and long-term monitoring. This means deeper experience with complex cases, newer surgical techniques like MIGS, and treatment decisions. In Dr Bhartiya’s case, her clinical work grounded in evidence based medicine rather than general practice.

Is Dr Shibal Bhartiya the best glaucoma specialist in Gurgaon?

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist with over 25 years of experience, including dedicated glaucoma and cornea training at AIIMS New Delhi and a structured fellowship at the University of Geneva. She is a Mayo Clinic Research Collaborator, has authored over 200 publications. She has over 1,585 five-star patient reviews on google, most of which call her the best glaucoma specialist or best eye doctor!

What do patients say about Dr Shibal Bhartiya’s care, beyond her credentials?

Across more than 1,580 five-star reviews on google, patients consistently mention the human experience of care. They always mention being heard without feeling rushed, having questions answered in plain language. Patients appreciate that treatment is explained in terms of daily quality of life rather than just numbers and scans. They also appreciate her ethical, personalised care, with no unnecessary tests or surgeries.

Most patients also call her the best glaucoma specialist, or the best eye doctor in Gurgaon. Most also appreciate how friendly she, and how she especially takes care of children. Several patients mention how much her second opinions, as well as teleconsultations, helped them.

Why does training in cornea matter for a glaucoma specialist?

Long-term glaucoma management almost always involves years of preservative-containing eye drops. This commonly cause ocular surface disease and dry eye over time. A glaucoma specialist with concurrent cornea training is able to recognise and manage this overlap directly. Which means Dr Bhartiya does not have to refer patients elsewhere for a problem that the glaucoma treatment itself helped cause.

What does training in optic neuropathies add to glaucoma care?

Glaucoma is itself a type of optic neuropathy. Some patients have overlapping or atypical optic nerve conditions that can be mistaken for glaucoma or missed alongside it. Specialists trained specifically in optic neuropathies, in addition to glaucoma, are better equipped to catch these atypical presentations early and avoid misdiagnosis.

What is MIGS and why does fellowship training in it matter?

MIGS (Minimally Invasive Glaucoma Surgery) is a newer category of glaucoma surgery. This is less invasive than traditional procedures, with faster recovery and fewer complications for suitable candidates. Specialists trained directly with international MIGS researchers are better positioned to judge which patients are good candidates and to perform it safely.

Should I get a second opinion before glaucoma surgery?

Yes, particularly for procedures that are not reversible. Glaucoma surgery decisions benefit from input by a specialist with broad surgical and research experience. The right choice depends on disease stage, risk stratification and patient preference. Dr Shibal Bhartiya explains options, eye anatomy, and how the disease is likely to progress over decades. Her second opinion is not based just current eye pressure.


Key Takeaways

  • Fellowship-level glaucoma training (AIIMS, University of Geneva) means deeper exposure to complex cases and advanced techniques like MIGS
  • Concurrent cornea training at AIIMS uniquely positions her to manage glaucoma-related dry eye and ocular surface disease
  • Geneva fellowship was within a Department of Clinical Neurosciences, adding specific training in optic neuropathies beyond glaucoma alone
  • Active research collaboration (Mayo Clinic) keeps treatment decisions current with global evidence
  • 1,580+ five-star reviews show consistency in patient trust and communication over time
  • Second opinions matter most before irreversible surgical decisions

This page is part of the Glaucoma Hub — covering diagnosis, monitoring, and treatment options for patients seeking specialist glaucoma care in Gurgaon. You may want to read about Glaucoma ProgressionRisk Stratification in Glaucoma, Glaucoma Specialist in Gurgaon. Also interesting could be Advanced Glaucoma Care in Gurgaon, Online Glaucoma Consultation, What Ethical Glaucoma Care Looks Like and Glaucoma Second Opinion — Gurgaon. Other articles of interest could be Advanced Glaucoma Care in Gurgaon, What Good Glaucoma Care Actually Optimises For, What Happens If Glaucoma Is Left Untreated? Please read More Glaucoma Eye Drops is Not Better Glaucoma Care, 5 Mistakes Patients Make in Glaucoma Care and Do You Really Need Treatment for Glaucoma?


About the Author

This article is about Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator. She is Clinical Director, Ophthalmology, at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

Dr Bhartiya has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1580+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google


Glaucoma Eye Drops: Prostaglandin

Prostaglandin Eye Drops for Glaucoma: Why Stopping Them Is Dangerous, Dr Shibal Bhartiya explains. Every week, a patient sits across…

Is This a Stye?

A stye is a painful red bump on the eyelid caused by an infection of an oil gland. Most improve with warm compresses, but persistent or recurrent lumps should be evaluated by an eye specialist.


Is This a Stye? How to Tell — and When It’s Something Els

You woke up with a red, tender lump on your eyelid. It hurts to blink. You are fairly sure it is a stye — and you may well be right. But a stye, a chalazion, and meibomian gland dysfunction (MGD) are three different conditions that look similar and get confused constantly, including by people who have had them before.

I see patients who have been treating a chalazion with warm compresses for six months, expecting it to behave like a stye. I see others who dismiss a persistently blocked lid gland as something that will pass. Knowing which one you have changes what you do next.

This article helps you identify your eyelid lump accurately, understand what causes it, and know when to stop waiting and come in.


Quick Answer: A stye is a painful, red, pus-filled lump that forms at the edge of the eyelid, usually from a bacterial infection of a lash follicle or oil gland. It typically resolves in 7 to 14 days with warm compresses. A chalazion is a firm, usually painless lump sitting further back on the lid — it is a blocked meibomian gland, not an infection, and often needs a clinic procedure to resolve. MGD is the underlying gland dysfunction that makes both conditions more likely to recur.


Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


Stye, Chalazion, or MGD: What Is the Difference?

These three conditions share the same anatomy — the eyelid’s oil-producing glands — but differ in cause, feel, and treatment.

A stye (also called a hordeolum) is an acute infection. It forms fast, hurts, and often has a visible yellow head. A chalazion is a chronic blockage without infection. It develops slowly, sits deeper in the lid, and feels like a hard pea under the skin. MGD is not a lump at all — it is a long-term dysfunction of the meibomian glands that creates the conditions for both styes and chalazia to keep coming back.

Stye

SymptomWhat It MeansWhat To Do
Red, painful lump at lash lineInfected lash follicle or external oil gland (Zeis or Moll)Warm compress 10 minutes, 4 times daily
Yellow or white head visiblePus collecting — classic external hordeolumDo not squeeze; let it drain on its own
Lump inside the eyelid, painfulInternal hordeolum — infected meibomian glandWarm compress; see a doctor if no improvement in 5 days
Swelling spreads to surrounding lidInfection spreading beyond the glandSee a doctor promptly — may need antibiotics
Recurring styes in same locationBlocked gland or underlying MGDRequires lid hygiene assessment, not just treatment of current stye
Stye in a childSame mechanism, but children rub eyes more and delay healingWarm compress; see a doctor if no change in 48 hours

Chalazion

SymptomWhat It MeansWhat To Do
Firm, round lump in mid-lid, not at lash lineBlocked meibomian gland — not an infectionWarm compress 10 minutes, 4 times daily for 4 to 6 weeks
Lump is painless or mildly tenderChronic granulomatous inflammation, not acuteNo antibiotics needed unless secondarily infected
Lump has been there over 6 weeks with no changeUnlikely to resolve without interventionSee an ophthalmologist for incision and curettage (I&C)
Lump pressing on eyeball, blurring visionMechanical pressure on corneaSee a doctor — this needs prompt attention
Recurrence after treatmentMGD driving repeated blockagesTreat the gland dysfunction, not just the lump
Large chalazion in a childCan cause amblyopia if it distorts visionPaediatric ophthalmology referral

MGD (Meibomian Gland Dysfunction)

SymptomWhat It MeansWhat To Do
Gritty, burning eyes — worse in the morningThickened meibum blocking tear film stabilityWarm compress daily + lid massage
Eyelids feel crusty or stuck on wakingInspissated gland secretionsLid hygiene twice daily with a clean cloth or lid wipe
Frequent styes or chalaziaMGD is the root cause — glands chronically blockedAddress MGD, not just individual lumps
Frothy or foamy tears at lid marginBacterial overgrowth on lid margin secondary to MGDTea tree oil lid scrubs if Demodex suspected; see a doctor
Reduced or absent oil expression from lidsGlands are atrophyingOphthalmologist assessment — early intervention matters
Dry eye symptoms alongside lid problemsTear film instability from poor meibum qualityOmega-3 supplements, warm compress, preservative-free drops

How to Tell a Stye from a Chalazion at Home

Location matters most. A stye sits at or very close to the lash line. A chalazion sits higher up on the lid, away from the lashes, and you can often feel it as a distinct firm nodule under the skin.

Pain is the second clue. Styes hurt. Chalazia usually do not, unless they become secondarily infected.

Speed of onset is the third. If it appeared overnight and is throbbing, it is likely a stye. If you noticed it gradually over days or weeks, suspect a chalazion.


What To Do at Home

These measures work for both styes and chalazia in the early stages.

  • Apply a warm compress for 10 minutes, four times a day. The compress must be genuinely warm — a flannel soaked in hot water and wrung out, or a clean heated eye mask. Warmth softens the blocked secretion and helps drainage.
  • After the compress, gently massage the lid in the direction of the lashes to encourage the gland to express.
  • Do not squeeze, pop, or pierce the lump. This risks spreading infection and causing scarring.
  • Remove all eye makeup while the lump is active. Mascara and eyeliner worsen gland blockage.
  • Do not wear contact lenses until the stye has fully resolved.
  • If you have recurrent episodes, start daily lid hygiene as a long-term habit — not just when a lump appears.

When To See a Doctor

Do not wait if you notice any of the following:

  • The lump is not improving after warm compresses
  • A chalazion has been present for more than 2 weeks without change
  • Swelling is spreading beyond the eyelid to the cheek or brow
  • You have fever, significant pain, or the eyelid is hot to touch
  • Vision is blurred or you feel pressure on the eye
  • The lump is in a child and affecting how the eye opens or moves
  • You have had the same lump treated and it has returned in the same spot
  • You are on immunosuppressants, have diabetes, or have had previous eyelid surgery

A lump that keeps returning in the same location needs a biopsy to rule out a sebaceous gland carcinoma. This is rare, but I do not skip it — and neither should your doctor.


Medical Treatment Options

For Styes

Most styes resolve with warm compresses alone. If they do not, an ophthalmologist may prescribe a short course of topical antibiotic drops or ointment. Oral antibiotics are rarely needed unless the infection has spread. A stye that is pointing but not draining can be lanced under local anaesthetic in a clinic setting — a quick, painless procedure.

For Chalazia

A chalazion that has not responded to four to six weeks of warm compresses needs an incision and curettage (I&C). This is a minor procedure done under local anaesthetic in clinic. The lid is everted, a small incision made on the inside surface, and the granulomatous contents removed. It takes under 10 minutes. Recurrence after I&C is common if underlying MGD is not treated.

An intralesional steroid injection is an alternative for patients who prefer to avoid surgery, or for chalazia in cosmetically sensitive locations. It works well for soft, early chalazia.

For MGD

MGD is a chronic condition and needs ongoing management, not just treatment of individual episodes. The approach includes:

  • Daily warm compress and lid massage (long-term, not just during flares)
  • Lid hygiene with baby shampoo or a dedicated lid scrub, twice daily
  • Omega-3 fatty acid supplementation — evidence supports this for meibum quality
  • In-clinic treatments including meibomian gland expression, intense pulsed light (IPL) therapy, or LipiFlow for more severe cases
  • Demodex treatment with tea tree oil lid scrubs if mite infestation is contributing

Frequently Asked Questions

Can I pop a stye at home?

No. Squeezing or piercing a stye risks spreading the infection deeper into the lid or into surrounding tissue. Let it drain on its own with warm compresses.

How long does a stye take to go away?

Most styes resolve in 7 to 14 days with consistent warm compresses four times daily. A lump that persists beyond two weeks needs a clinic review.

Is a chalazion the same as a stye?

No. A stye is an acute bacterial infection at the lash line. A chalazion is a chronic blocked gland, usually painless, sitting deeper in the lid.

Why do I keep getting styes?

Recurrent styes usually indicate underlying meibomian gland dysfunction (MGD), which blocks glands repeatedly. Treating the MGD — not just each individual stye — breaks the cycle.

Can MGD cause a stye?

Yes. MGD thickens the oil secretions in the meibomian glands, making blockage and secondary infection more likely. It is the most common underlying cause of recurrent styes and chalazia.

When does a chalazion need surgery?

A chalazion needs incision and curettage if it has not responded to warm compresses after four to six weeks, is large enough to press on the eye, or is affecting vision or lid position.


Key Takeaways

  • A stye is painful, fast-forming, and sits at the lash line — it is an infection
  • A chalazion is firm, usually painless, and sits deeper in the lid — it is a blockage, not an infection
  • MGD is the root cause of most recurrent styes and chalazia
  • Warm compresses four times daily are the first treatment for both styes and chalazia
  • Never squeeze or pop an eyelid lump
  • A chalazion lasting more than six weeks needs a clinic procedure
  • Recurrent lumps in the same spot need a biopsy to rule out malignancy

Book a Consultation

If your eyelid lump has not resolved in two weeks, keeps coming back, or is affecting your vision or comfort, I would encourage you to come in for an assessment. Styes and chalazia are very treatable — but they need the right diagnosis first, particularly if MGD is driving the pattern.

I see patients at my clinic in Gurugram and offer second opinions for eyelid conditions that have not responded to previous treatment.

[Book an Appointment →]


This article is part of the Dry Eye Hub. Please also read Basics of Dry EyeDry Eye Second Opinion and Dry Eye: A Chronic DiseaseWhy Vision Becomes Blurred After Reading or Screen Use, and Why Are Your Dry Eye Drops Not Working may also help you understand your problem better.

You may also want to read this article written by Dr Bhartiya for NDTV online. And listen to her talk about dry eyes here.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Glaucoma Progressing Despite Normal Pressure: 24 Hour IOP

Glaucoma progression despite apparently controlled intraocular pressure is one of the most disorienting experiences a patient can face. It is also one of the most common reasons patients seek a glaucoma second opinion. The reason is almost always the same: daytime clinic readings capture one moment. They do not capture what happens at night, explains Dr Shibal Bhartiya.

Not all glaucoma medications lower pressure around the clock. Brimonidine and timolol both show significantly reduced activity after midnight. A patient whose pressure is controlled at 11 am may have entirely uncontrolled pressure at 3 am — and no standard clinic visit will reveal this.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

My Glaucoma Is Progressing But My Pressure Is Always Normal. What Is Going On?

He was in his early sixties — careful, informed, and deeply confused.

He came to me for a second opinion after five to six years under glaucoma care. His file was meticulous. His lifestyle was exemplary — non-smoker, controlled blood pressure, controlled blood sugars. He was on two medications: timolol and brimonidine. His baseline IOP had been 26 to 27 mmHg. On treatment, it now sat at 13 to 14 mmHg at every clinic visit for years.

By every standard measure, he was a success story. But his glaucoma was still progressing.

He was not angry. He was bewildered. I have done everything right, he told me. Why is this still happening?

That question deserved a better answer than he had been given. The answer was in the hours nobody had measured.

The question nobody had asked

I looked at his records and asked him one thing: had anyone ever done a diurnal variation for him? A 24-hour IOP measurement, mapped across day and night? Or a Water Drinking Test?

He said no.

We enrolled him in a study using the Triggerfish sensor — a contact lens device that records continuous IOP fluctuation over 24 hours. The device does not measure absolute pressure values, but it maps the pattern of fluctuation with precision.

The night-time readings were almost double the daytime values.

Most clinic visits measure pressure once, mid-morning, when he was up and about. That is the reading least likely to catch a nocturnal spike. His reassuring numbers, always 13, always 14, had been capturing only half the story. The other half was unfolding while he slept, while no one was measuring, while his optic nerve absorbed damage that nobody anticipated.

Why his medications were failing him at night

The reason was pharmacological, and it is something worth stating clearly: brimonidine and timolol do not work at night. Their pressure-lowering effect drops sharply in the late hours. His reassuring clinic readings — always 13, always 14 — had been capturing only half the story. The other half was invisible, unfolding while he slept, while no one was measuring, while his optic nerve absorbed damage that nobody anticipated.

This is not a failure of the medications. It is a failure of the measurement system — and of the assumption that a daytime number tells the whole story.

What Doctors Often Miss

Brimonidine and timolol do not work at night. This is pharmacology, not failure — their pressure-lowering effect drops sharply in the late hours. It is a well-documented limitation that is not always communicated to patients or factored into treatment decisions.

The result is that a patient can have genuinely excellent daytime control and entirely uncontrolled nocturnal pressure simultaneously. Standard clinic visits — timed to office hours — will never detect this.

The other missed step is the diurnal variation test itself. It is one of the most underused and highest-yield investigations in glaucoma management. It is rarely ordered unless a specialist specifically suspects nocturnal IOP spikes. If your glaucoma is progressing despite apparently good readings, this investigation is worth asking for by name — and a glaucoma second opinion is always reasonable in this situation.


Why Prostaglandins Are First-Line for a Reason

We switched him to bimatoprost 0.01% — a prostaglandin analogue. Prostaglandins are the only class of glaucoma medication proven to work continuously across 24 hours. They do not lose activity at night.

That was in 2012 to 2013. He has been stable for over six years.

One molecule change. One question that had never been asked. Six years of stability that five years of treatment had never delivered.


Symptoms, Pressure Patterns, and When to Investigate

FindingLikely CauseWhen to Investigate Further
Glaucoma progressing despite good clinic IOPNocturnal IOP spike not captured by daytime readingsRequest 24-hour diurnal variation assessment
On timolol or brimonidine, still progressingNight-time loss of drug efficacyAsk whether a prostaglandin has been considered
Visual field deterioration at routine reviewOngoing IOP fluctuation between clinic visitsIOP fluctuation may be as damaging as sustained elevation
Good compliance, good lifestyle, still progressingMedication class mismatch for 24-hour coverageSecond opinion from glaucoma specialist
Pressure controlled but OCT showing RNFL thinningStructural damage continuing despite IOP numbersFull diurnal assessment and treatment review

What This Means for You

If your glaucoma is progressing despite readings that look controlled, the readings may be incomplete — not the whole story, only the morning chapter.

The questions worth asking at your next visit: Has my pressure ever been measured at night? Has anyone checked whether my medications work across 24 hours? Has a prostaglandin analogue been considered as my primary medication?

You are not doing anything wrong. The measurement system may simply be missing the hours that matter most.


If your glaucoma is progressing despite treatment, or if you have never had a 24-hour IOP assessment, a specialist review may give you answers years of routine care have not.

Book a consultation or second opinion with Dr Shibal Bhartiya in Gurgaon.
+91 88826 38735 | www.drshibalbhartiya.com


FAQs

My glaucoma is progressing but my eye pressure is always normal at the clinic. How is that possible?

Clinic readings capture pressure at one moment, usually mid-morning. Eye pressure fluctuates across 24 hours. Certain medications — including timolol and brimonidine — lose effectiveness at night. If pressure spikes at 2 am, no daytime clinic visit will catch it. That spike is still damaging your optic nerve, invisibly, visit after visit.

What is a diurnal variation test and do I need one?

A diurnal variation maps your eye pressure across the full day and night. It is recommended when glaucoma is progressing despite apparently controlled pressure, when you are on medications that may not provide round-the-clock coverage, or when your specialist suspects night-time IOP spikes. It is one of the most underused and highest-yield tests in glaucoma management.

Why are prostaglandin eye drops the first choice for glaucoma?

Prostaglandins are the only class of glaucoma medication that works continuously across 24 hours. Other drugs — including timolol and brimonidine — show significantly reduced activity at night. For long-term pressure control, the night-time hours matter as much as the daytime ones. This is why prostaglandin analogues are recommended as first-line therapy in international glaucoma guidelines.

Can glaucoma progress even when I am doing everything right?

Yes, and it is more common than patients realise. Controlled daytime pressure, healthy lifestyle, medication compliance — none of these guarantee protection if night-time IOP is unaddressed. Progression despite apparent control is a signal to investigate further, not to doubt yourself. A glaucoma second opinion is always reasonable in this situation.

Should I ask for a 24-hour IOP test if my glaucoma is progressing?

Yes. If your visual fields are declining despite good clinic readings, a diurnal variation assessment is a reasonable and important next step. Ask your glaucoma specialist specifically about this. It is a question worth asking at your next visit.


This page is part of the Advanced Glaucoma Care hub. Read about the full spectrum of glaucoma diagnosis and treatment. Please also read about Diurnal Variation of IOP, Target IOP and Glaucoma Eye Drops.

You may want to watch this podcast I did several years ago, for Health Talks.


Note: Contact Lens Monitor for Continuous IOP Monitoring

Triggerfish® contact lens sensor is a specialised diagnostic contact lens used in glaucoma care to monitor intraocular pressure (IOP)–related changes over 24 hours. Unlike routine pressure measurements taken during clinic hours, the Triggerfish lens (Sensimed Triggerfish) helps detect pressure fluctuations that may occur at night or outside OPD visits, which can sometimes explain progression despite apparently controlled readings. It does not measure pressure directly in mmHg but records circumferential corneal changes related to IOP patterns, helping glaucoma specialists better understand individual risk profiles and treatment needs in selected patients.

Dr Shibal Bhartiya was the first doctor in India to use the Triggerfish® contact lens sensor for Continuous IOP Monitoring in clinical practice. Her initial experiences on Intraocular pressure (IOP) related pattern in patients with primary angle closure (PAC) and primary angle closure glaucoma (PACG) before and after laser peripheral iridotomy (LPI) was presented at ARVO, in Orlando Florida in 2014

IOP Fluctuation and Angle Closure Glaucoma

IOP fluctuation is a particular concern in angle closure disease, where pressure spikes can be steep and are frequently missed by routine daytime readings. Dr Bhartiya’s published research has examined this directly. A 2015 study in the Journal of Current Glaucoma Practice, Diurnal Intraocular Pressure Fluctuation in Eyes with Angle-Closure (Bhartiya S, Ichhpujani P; PMID: 26997828), investigated IOP fluctuation across the day in 77 newly diagnosed angle closure patients and documented the range and pattern of diurnal variation in this group.

A 2019 review in the Romanian Journal of Ophthalmology, Diurnal Variation of IOP in Angle Closure Disease: Are We Doing Enough? (Bhartiya S et al.; PMID: 31687621), went further — finding that many clinical decisions in angle closure glaucoma management are based on only one or two IOP measurements, and arguing that this is insufficient given the established circadian rhythm of IOP and its direct correlation with glaucoma progression. Taken together, these papers make the case that angle closure patients may be among the most undertreated precisely because their worst pressure moments are the least observed.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (PubMed-indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks, span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1,500+ Five Star Patient Reviews — Google Business Profile

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review. | www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google